Obesity as a predictor of biochemical recurrence and survival after radiation therapy for prostate cancer
β Scribed by David Palma; Tom Pickles; Scott Tyldesley; Prostate Cohort Outcomes Initiative
- Book ID
- 109053268
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 138 KB
- Volume
- 100
- Category
- Article
- ISSN
- 1464-4096
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Depending on initial prognostic factors, an estimated 10%β60% of men who undergo definitive radiation therapy for prostate cancer may experience a biochemical recurrence. Even though hormonal therapy is standard for metastatic recurrences, no consensus exists on optimal salvage therapy
## Abstract ## BACKGROUND. Given the limited data regarding the impact of obesity on treatment outcomes after external beam radiation therapy (EBRT) for the definitive treatment of prostate cancer, the authors sought to evaluate the effect of obesity as measured by body mass index (BMI) on biochem